Related Experiment Video
Updated: Feb 17, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Immunotherapy for Prostate Cancer: Where We Are Headed
Giuseppe Schepisi1, Alberto Farolfi2, Vincenza Conteduca3
1Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014 Meldola, Italy. giuseppe.schepisi@irst.emr.it.
Emerging immunotherapies offer new treatment options for prostate cancer patients. This review discusses the potential of these novel drugs in managing metastatic prostate cancer, a leading cause of cancer death in men.
Area of Science:
- Oncology
- Immunology
Background:
- Prostate cancer is a prevalent malignancy in men globally.
- It is a significant cause of cancer-related mortality.
- Metastatic prostate cancer presents treatment challenges.
Purpose of the Study:
- To review the role of emerging immunotherapeutic drugs in prostate cancer.
- To highlight advancements in novel treatment strategies.
Main Methods:
- Literature review of recent studies on immunotherapies for prostate cancer.
- Discussion of current and potential applications of immunotherapeutic drugs.
Main Results:
- Immunotherapy represents a novel frontier in cancer treatment.
- Emerging immunotherapies show potential in managing various tumor types, including prostate cancer.
Conclusions:
- Immunotherapeutic drugs are a promising new avenue for prostate cancer management.
- Further research is ongoing to explore their full potential in patients.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Microorganisms in Medicine and Therapeutics

